DU-14 is a potent steroid sulfatase inhibitor with an IC50 of 55.8 nM. DU-14 inhibits the MCF-7 cell proliferation (IC50 = 38.7 nM). DU-14 has neuroprotective effects against neurotoxic Aβ, suggesting that up-regulation of endogenous DHEAS by DU-14 could be beneficial to the alleviation of Aβ-induced impairments in spatial memory and synaptic plasticity[1][2][3].

Duloxetine (hydrochloride) (Standard) is the analytical standard of Duloxetine (hydrochloride). This product is intended for research and analytical applications. Duloxetine hydrochloride ((S)-Duloxetine hydrochloride) is a serotonin-norepinephrine reuptake inhibitor (SNRI) with a Ki of 4.6 nM, used for treatment of major depressive disorder and generalized anxiety disorder (GAD)[1][2].

DUOX1 Human Pre-designed siRNA Set A contains three designed siRNAs for DUOX1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

DUOX2 Human Pre-designed siRNA Set A contains three designed siRNAs for DUOX2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

DUOXA1 Human Pre-designed siRNA Set A contains three designed siRNAs for DUOXA1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

DUOXA2 Human Pre-designed siRNA Set A contains three designed siRNAs for DUOXA2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

Durlobactam sodium salt (ETX2514) is a broad-spectrum β-lactamase inhibitor with IC50s of 4, 14 and 190 nM for Class A KPC-2, Class C AmpC and Class D OXA-24, respectively. For the treatment of drug-resistant Gram-negative bacteria including Acinetobacter baumannii[1].

Durlobactam sodium salt (ETX2514) is a broad-spectrum β-lactamase inhibitor with IC50s of 4, 14 and 190 nM for Class A KPC-2, Class C AmpC and Class D OXA-24, respectively. For the treatment of drug-resistant Gram-negative bacteria including Acinetobacter baumannii[1].

Durlobactam sodium salt (ETX2514) is a broad-spectrum β-lactamase inhibitor with IC50s of 4, 14 and 190 nM for Class A KPC-2, Class C AmpC and Class D OXA-24, respectively. For the treatment of drug-resistant Gram-negative bacteria including Acinetobacter baumannii[1].

Durlobactam sodium salt (ETX2514) is a broad-spectrum β-lactamase inhibitor with IC50s of 4, 14 and 190 nM for Class A KPC-2, Class C AmpC and Class D OXA-24, respectively. For the treatment of drug-resistant Gram-negative bacteria including Acinetobacter baumannii[1].

Durlobactam sodium salt (ETX2514) is a broad-spectrum β-lactamase inhibitor with IC50s of 4, 14 and 190 nM for Class A KPC-2, Class C AmpC and Class D OXA-24, respectively. For the treatment of drug-resistant Gram-negative bacteria including Acinetobacter baumannii[1].

Durvalumab (anti-PD-L1)(MEDI 4736) is a human anti-PD-L1 protein monoclonal antibody[1]. Durvalumab (anti-PD-L1) completely blocks PD-L1 binding to PD-1 and CD80, IC 50 are 0.1 and 0.04 nM[1] respectively[1][2].

Durvalumab (anti-PD-L1)(MEDI 4736) is a human anti-PD-L1 protein monoclonal antibody[1]. Durvalumab (anti-PD-L1) completely blocks PD-L1 binding to PD-1 and CD80, IC 50 are 0.1 and 0.04 nM[1] respectively[1][2].

DUS2 Human Pre-designed siRNA Set A contains three designed siRNAs for DUS2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

DUS3L Human Pre-designed siRNA Set A contains three designed siRNAs for DUS3L gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

DUSP1 Human Pre-designed siRNA Set A contains three designed siRNAs for DUSP1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

DUSP10 Human Pre-designed siRNA Set A contains three designed siRNAs for DUSP10 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

DUSP11 Human Pre-designed siRNA Set A contains three designed siRNAs for DUSP11 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

DUSP12 Human Pre-designed siRNA Set A contains three designed siRNAs for DUSP12 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

DUSP13 Human Pre-designed siRNA Set A contains three designed siRNAs for DUSP13 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

DUSP14 Human Pre-designed siRNA Set A contains three designed siRNAs for DUSP14 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

DUSP15 Human Pre-designed siRNA Set A contains three designed siRNAs for DUSP15 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

DUSP16 Human Pre-designed siRNA Set A contains three designed siRNAs for DUSP16 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

DUSP18 Human Pre-designed siRNA Set A contains three designed siRNAs for DUSP18 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

DUSP19 Human Pre-designed siRNA Set A contains three designed siRNAs for DUSP19 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

DUSP2 Human Pre-designed siRNA Set A contains three designed siRNAs for DUSP2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

DUSP22 Human Pre-designed siRNA Set A contains three designed siRNAs for DUSP22 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

DUSP23 Human Pre-designed siRNA Set A contains three designed siRNAs for DUSP23 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

DUSP26 Human Pre-designed siRNA Set A contains three designed siRNAs for DUSP26 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

DUSP3 Human Pre-designed siRNA Set A contains three designed siRNAs for DUSP3 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

DUSP4 Human Pre-designed siRNA Set A contains three designed siRNAs for DUSP4 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

DUSP5 Human Pre-designed siRNA Set A contains three designed siRNAs for DUSP5 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

DUSP6 Human Pre-designed siRNA Set A contains three designed siRNAs for DUSP6 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

DUSP7 Human Pre-designed siRNA Set A contains three designed siRNAs for DUSP7 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

DUSP8 Human Pre-designed siRNA Set A contains three designed siRNAs for DUSP8 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

DUSP9 Human Pre-designed siRNA Set A contains three designed siRNAs for DUSP9 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

DUT Human Pre-designed siRNA Set A contains three designed siRNAs for DUT gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

Dutasteride (Standard) is the analytical standard of Dutasteride. This product is intended for research and analytical applications. Dutasteride (GG745) is a potent inhibitor of both 5α-reductase isozymes. Dutasteride may possess off-target effects on the androgen receptor (AR) due to its structural similarity to DHT[1].

Dutasteride-13C,15N,d is 15N and deuterated labeled Dutasteride (HY-13613). Dutasteride (GG745) is a potent inhibitor of both 5α-reductase isozymes. Dutasteride may possess off-target effects on the androgen receptor (AR) due to its structural similarity to DHT[1].

DUX1 Human Pre-designed siRNA Set A contains three designed siRNAs for DUX1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

DUX4 Human Pre-designed siRNA Set A contains three designed siRNAs for DUX4 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

DUXA Human Pre-designed siRNA Set A contains three designed siRNAs for DUXA gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

DUXB Human Pre-designed siRNA Set A contains three designed siRNAs for DUXB gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

DV-B-120 is a competitive inhibitor for dengue virus (DENV) with IC50s of 5.35, 7.39, 10.49 and 8.58 μM, for DENV-1, DENV-2, DENV-3 and DENV-4, respectively, by inhibiting NS2B-NS3 protease. DV-B-120 exhibits antiviral activity through inhibition of DENV replication[1].

DVL1 Human Pre-designed siRNA Set A contains three designed siRNAs for DVL1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

DVL2 Human Pre-designed siRNA Set A contains three designed siRNAs for DVL2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

DVL3 Human Pre-designed siRNA Set A contains three designed siRNAs for DVL3 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

DXO Human Pre-designed siRNA Set A contains three designed siRNAs for DXO gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

DXPS-IN-1 (Compound 8) is an inhibitor of 1-deoxy-D-xylulose-5-phosphate synthase (DXPS) with a Ki value of 2.9 nM against EcDXPS. DXPS-IN-1 exhibits antibacterial activity[1].